In summary, we demonstrated that the expression pattern of vezatin is abnormal in epilepsy and that vezatin regulates seizure activity by affecting AMPAR-mediated NST and the surface expression of GluA1, which is involved in PKA-mediated phosphorylation of GluA1 at serine 845. The gene discussed is GRIA1; the disease is epilepsy.